Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2021 09:54 ET | Source: University of Minnesota Medical School

University of Minnesota Medical School launches clinical trial studying metformin treatment for COVID-19

Minneapolis / St. Paul, March 15, 2021 (GLOBE NEWSWIRE) -- A new multi-site clinical trial led by the University of Minnesota Medical School is studying the effectiveness of metformin, a generic...
March 15, 2021 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Positive Biomarker Data from Phase 2 Clinical Trial of ATYR1923 Demonstrating Anti-Inflammatory Effects in COVID-19 Patients with Severe Respiratory Complications

Data provides first-in-patient mechanistic proof-of-concept for ATYR1923. ATYR1923 reduced key inflammatory cytokines that are implicated in sarcoidosis and other ILDs, consistent with findings...
October 19, 2020 09:00 ET | Source: Rénibus Therapeutics Inc.

Renibus Therapeutics Announces Presentations at the American Society of Nephrology Kidney Week 2020

DALLAS, Texas, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it will present five abstracts at the American Society of...
April 21, 2020 08:30 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Phase 2 Study of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications Following FDA Acceptance of IND Application

SAN DIEGO, April 21, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...
April 15, 2020 08:30 ET | Source: Multiverse Investment Fund I, LP

Multiverse Investment Fund Announces Portfolio Company’s Commencement of Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19)

Multiverse Investment Fund Portfolio Company Begins Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19) ARDS has been identified as the leading cause...
April 07, 2020 09:00 ET | Source: Informa Business Intelligence

Informa Pharma Intelligence Launches Free COVID-19 Content Hub

LONDON, April 07, 2020 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, today announces the launch of a free coronavirus (COVID-19/SARS-CoV-2) content hub designed to provide key information related...